What is Embolotherapy Market?
Embolotherapy is a type of endovascular treatment that aims to occlude abnormal blood vessels in order to control bleeding, close fistulae or arteriovenous malformations, devascularise organs, reduce tumors, and much more. To achieve blocking, embolotherapy performs minimally-invasive methods and several embolic agents, such as gel foam, coils, balloons, and angiographic catheters to reach exact and significant results. As the field covers such a wide range of treatment possibilities, from recognized therapies such as TACE, UFE, and venous embolization, to some of the less commonly known applications such as hemorrhoid and arthritis embolization, it continues to advance in order to become more precise, more evidence-based and even more impactful in the years to come which is boosting the growth of the market.
The market study is being classified by Type (Embolic Agents, Microspheres, Embolic Coils (Detachable Coils, Pushable Coils), Liquid Embolic Agents, Embolic Plug Systems, Detachable Balloons, Support Devices, Microcatheters and Guidewires) and major geographies with country level break-up.
Boston Scientific Corporation (United States), Merit Medical Systems (United States), Terumo Corporation (Japan), Medtronic plc (Ireland), Johnson & Johnson (United States), Stryker Corporation (United States), BTG plc (United Kingdom), Penumbra, Inc. (United States), Cook Medical (United States), Abbott Laboratories (United States), Acandis GmbH (Germany) and BALT Extrusion (France) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Sirtex Medical Limited (Australia), Kaneka Corporation (Japan) and Meril Life Sciences Pvt. Ltd. (India).
In the embolotherapy market, it has been observed that most of the companies are upgrading or introducing innovative products. They rely on strategies such as mergers & acquisitions, product development, geographical expansion, technological innovation, and sourcing strategies to enhance their market share. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Embolotherapy market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Embolotherapy market by Type, Application and Region.
On the basis of geography, the market of Embolotherapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rising Incidences of Peripheral Vascular Diseases, Liver Cancer, and Strokes
- Increasing Preference for Minimally Invasive Procedures
- Increasing Investments and Technological Advancements in Embolotherapy Devices
- Availability of Alternative Therapies
- Unfavorable Regulatory Scenario
- Increasing Applications of Embolization Devices
- Growth Opportunities in Emerging Markets
- Dearth of Skilled Surgeons
Market Leaders and some development strategies
In Aug 2019, Boston Scientific Corporation announced the completion of its acquisition of BTG plc. pursuant to the previously announced scheme of arrangement. BTG develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals.
In Jan 2019, MicroVention, Inc. announced the FDA Premarket Approval (PMA) for the WEB Aneurysm Embolization System for the treatment of intracranial wide-neck bifurcation aneurysms. The WEB System is the first and only PMA approved device in the new category of intravascular flow disruptors for aneurysm embolization.
Key Target AudienceEmbolotherapy Devices Manufacturers, Embolotherapy Service Providers, Embolotherapy Industry Association, Research and Development Institutes, Potential Investors, Regulatory Bodies, Hospitals and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase